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Abstract
We recently demonstrated, in rat brain slices, that the usual excitation by noradrenaline (NA) of hypocretin/orexin (hcrt/orx)
neurons was changed to an inhibition following sleep deprivation (SD). Here we describe that in control condition (CC), i.e.
following 2 hours of natural sleep in the morning, the a2-adrenergic receptor (a2-AR) agonist, clonidine, had no effect on
hcrt/orx neurons, whereas following 2 hours of SD (SDC), it hyperpolarized the neurons by activating G-protein-gated
inwardly rectifying potassium (GIRK) channels. Since concentrations of clonidine up to a thousand times (100 mM) higher
than those effective in SDC (100 nM), were completely ineffective in CC, a change in the availability of G-proteins is unlikely
to explain the difference between the two conditions. To test whether the absence of effect of clonidine in CC could be due
to a down-regulation of GIRK channels, we applied baclofen, a GABAB agonist known to also activate GIRK channels, and
found that it hyperpolarized hcrt/orx neurons in that condition. Moreover, baclofen occluded the response to clonidine in
SDC, indicating that absence of effect of clonidine in CC could not be attributed to down-regulation of GIRK channels. We
finally tested whether a2-ARs were still available at the membrane in CC and found that clonidine could reduce calcium
currents, indicating that a2-ARs associated with calcium channels remain available in that condition. Taken together, these
results suggest that a pool of a2-ARs associated with GIRK channels is normally down-regulated (or desensitized) in hcrt/orx
neurons to only become available for their inhibition following sleep deprivation.
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Introduction
The hypocretin/orexin (hcrt/orx) neurons of the hypothalamus
play an important role in maintaining arousal, since their absence
results in narcolepsy with cataplexy (for reviews, see [1–4]). The
hcrt/orx neurons exert their influence during waking when they
discharge selectively [5,6], and through widespread projections [7]
and excitatory actions upon multiple systems including all the
activating and arousal systems in the brain [8].
Using rat brain slices, we have recently shown that hcrt/orx
neurons are in turn normally excited by the multiple neurotrans-
mitters of the arousal systems, including importantly noradrena-
line [9]. However, using sleep-deprivation (SD), an approach used
extensively to investigate sleep regulation and homeostasis (for
recent review [10]), we discovered that following two hours of
gentle SD, hcrt/orx neurons changed their response to noradren-
aline from an excitation to an inhibition [11]. We proposed that
such a phenomenon could contribute to the sleepiness that
accompanies SD since during the natural sleep-wake cycle, the
hcrt/orx neurons diminish firing before and cease firing during
sleep [5,6] and since their absence results in narcolepsy associated
with increased daytime sleepiness (for review [12]).
Our goal in the present study was to investigate further the
mechanisms underlying the emergence of inhibitory responses to
noradrenaline following SD in rat brain slices. Our results suggest
that a pool of a2-ARs associated with GIRK channels must
become available for inhibition of hcrt/orx cells with SD.
Results
The a2 agonist clonidine hyperpolarizes hcrt/orx neurons
following sleep-deprivation
To investigate the mechanism underlying the hyperpolarizing
response to noradrenaline following sleep deprivation [11], hcrt/
orx neurons were identified according to criteria illustrated in a
previous publication [13] and tested for their response to the bath-
application of the a2-AR agonist clonidine in either CC or SDC
(see Fig. 1A). It was found that in CC, hcrt/orx neurons never
responded to clonidine applied at either 100 nM (n=6/6, not
shown), 10 mM (n=6/6, Fig. 1B) or even 100 mM (n=3/3, not
shown). In contrast, almost all hcrt/orx neurons decreased their
activity in response to the agonist in SDC (n=5/6 with clonidine
at 100 nM, Fig. 1C and n=9/10 with clonidine at 10 mM,
Fig. 1D). These results indicate that the difference between the CC
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of G-proteins (see Discussion).
That the hyperpolarizing response was mediated by a2-ARs was
confirmed by using a selective a2-AR antagonist, idoxazan
(10 mM; n=3/3, Fig. 1E), which in SDC completely blocked the
response to clonidine at 10 mM. To test whether the inhibitory
action of clonidine could result from the sleep deprivation
procedure, we then applied the same procedure at a time of
minimal homeostatic sleep pressure, i.e. during the dark period
between 8 and 10 pm (see Methods), and found that, in this case,
cells never responded to clonidine (n=4/4, not shown).
These data show that the hyperpolarizing response of hcrt/orx
neurons to noradrenaline that we have previously demonstrated in
SDC [11] actually depend on a2-ARs which are regulated by SD.
It is noteworthy that, in contrast, the depolarizing and excitatory
responses to noradrenaline in CC described previously [11], were
found here to depend on a1-ARs as they were mimicked by the a1-
AR agonist L-phenylephrine. These a1-AR-dependent responses
were however not regulated in the same manner as the a2-AR-
dependent responses, as they did not change in between CC and
SDC (n=17/26 in CC and 5/12 in SDC; p=0.15, Fischer exact
test).
Clonidine-dependent hyperpolarization following sleep-
deprivation is mediated by GIRK channels
Since the activation of a2-ARs is known to hyperpolarize
neurons through the opening of GIRK channels [14], we tested
whether such channels were indeed implicated in the present
effects of clonidine. For that purpose we first used barium which,
at a small concentration (200 mM), is known to act as a blocker of
GIRK channels [15]. When clonidine at 10 mM was applied in
presence of barium in SDC, it was found to have no effect (n=4/4
in current clamp, Fig. 1F, and n=3/3 in voltage-clamp, not
shown). To further demonstrate the implication of GIRK channels
in SDC, clonidine effects were studied while applying voltage
ramps from 2150 to +10 mV. When, in CC, current-voltage
relationships before (artificial cerebrospinal fluid, ACSF, see
Methods) and during application of clonidine at 10 mM were
compared, we found that clonidine had no effect (Fig. 2A, ACSF
vs clonidine, n=5). In contrast, in SDC, current-voltage
relationships before (ACSF) and during application of 10 mM
clonidine revealed currents (Fig. 2B, n=4; mean Einv 6
SEM=254.062.94 mV) that were small and outward at
potentials positive to EK (set at 255 mV, see Methods) but
strongly rectified and became inward below EK.
GIRK channels are not down-regulated in the control
condition
One possible explanation for the above results could be that
GIRK channels are not available in CC and become available in
SDC. To test this hypothesis, we applied baclofen, a selective
GABAB receptor agonist, also known to activate GIRK channels
in many CNS neurons [15]. In current-clamp, whereas clonidine
had no effect in CC, baclofen at 10 mM, hyperpolarized every cell
(n=5/5, not shown). To demonstrate that the baclofen effect was
Figure 1. Effects of clonidine on identified hcrt/orx neurons. (A)
Experimental protocol. Animals are maintained in a 12 h light/dark
cycle (lights on from 8:00 am to 8:00 pm). After a normal cycle of sleep
and waking, rats were either allowed to sleep from 8:00 to 10:00 am or
kept fully awake; being gently sleep deprived for the same 2 hours
interval. Recordings are made between 11 am and 1 pm in neurons
obtained from rats which had slept (control condition, CC) or had been
sleep deprived (sleep deprived condition, SDC) between 8 and 10 am.
(B) Absence of effect of 10 mM clonidine in CC. (C–D) In SDC hcrt/orx
neurons are inhibited by clonidine at both 100 nM (C) and 10 mM (D).
(E) Idoxazan at 10 mM impedes the inhibitory and hyperpolarizing effect
of clonidine in SDC. (F) Barium at 200 mM impedes the inhibitory and
hyperpolarizing effect of clonidine in SDC.
doi:10.1371/journal.pone.0016672.g001
Figure 2. Effects of clonidine on hcrt/orx neurons in control
and sleep deprived conditions. (A) In CC, as evident by subtraction
of the current-voltage relationships obtained at voltages from 2150 to
+10 mV before (ACSF) and during application of clonidine at 10 mM,
bath-application of clonidine did not elicit any current in hcrt/orx
neurons. (B) In SDC, in contrast, subtraction of the currents measured in
presence and absence of clonidine revealed a clonidine-dependent
inward potassium current. Indeed, the inversion potential is around
255 mV which is the inversion potential of potassium in the
experimental conditions (see Methods).
doi:10.1371/journal.pone.0016672.g002
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of baclofen using voltage-clamp ramps. As illustrated in Fig. 3A,
baclofen triggered an inwardly rectifying current (n=4), thereby
suggesting that in CC, GIRK channels are still available on the
membrane.
To exclude the possibility that clonidine and baclofen acted on
different populations of GIRK channels, we applied clonidine in
SDC, following a prior application of baclofen, and found that
clonidine evoked no additional effect in that condition (Fig. 3B,
n=4; compare with Fig. 2B). Altogether these data indicate that
the lack of effect of clonidine in CC cannot be explained by a
down-regulation of GIRK channels.
Clonidine reduces calcium currents in control condition
Another possibility to explain the lack of responsiveness of hcrt/
orx neurons to clonidine in CC could be that the a2-ARs become
down-regulated (or desensitized) in that situation [14,16]. If this
were the case, one would expect that modulation of other
membrane currents by these receptors would also be impeded.
Since activation of a2-ARs often produces a decrease in calcium
currents [17], we examined whether this response to clonidine
occurred in CC. For this purpose, cells had first to be identified
electrophysiologically [13] using a regular electrode solution and
then patched a second time with a cesium-containing electrode to
decrease potassium currents. Some cells were in addition injected
with neurobiotin for immunohistochemical identification (inset of
Fig. 4A). Electrophysiologically identified hcrt/orx cells were then
submitted, every 10 seconds, to a voltage step from 290 to 0 mV
to evoke an inward calcium current (Fig. 4A). As evidenced in
Fig. 4A and B, application of clonidine at 10 mM reversibly
decreased the total calcium current (n=5). These results suggest
that in CC, functional a2-ARs linked to calcium channels must still
be available at the membrane.
Discussion
This study shows that in CC, hcrt/orx neurons were insensitive
to the a2-AR agonist, clonidine, whereas they were hyperpolar-
ized, through the activation of GIRK channels, in SDC. Several
lines of evidence suggest that a pool of a2-ARs associated with
GIRK channels becomes available for inhibition of hcrt/orx cells
with sleep deprivation.
In our original study on the consequences of SD [11], we
showed that, in juvenile rat brain slices, noradrenaline usually
depolarized and excited hcrt/orx neurons in CC, but hyperpo-
larized and inhibited the same cells in SDC. These data stood in
contrast to those in mice, in which noradrenaline always
hyperpolarized hcrt/orx cells [18,19]. It is noteworthy that since
our own (unpublished) observations are in agreement with these
data, the mouse model could not be used in the present study to
further explore this process. In mice, the hyperpolarization of
hcrt/orx cells depended on a2-ARs, but a1-dependent excitatory
responses could also be evoked by L-phenylephrine, although only
after the selective blockage by idoxazan [18], indicating that under
baseline laboratory conditions in mice the a2-ARs predominate.
Not surprisingly, we found that the hyperpolarizing responses to
noradrenaline in SDC depended on a2-ARs since they could be
mimicked by clonidine and antagonized by idoxazan. It is
noteworthy, in contrast, that the excitatory action of noradrenaline
observed in CC, which depends on a1-ARs, since it was mimicked
by L-phenylephrine, was not similarly regulated, since it did not
change significantly between CC and SDC. This indicates that the
Figure 3. GIRK channels are present on hcrt/orx neurons. (A)
Subtraction of the current-voltage relationships obtained at voltages
from 2150 to +10 mV before (ACSF) and during application of baclofen
at 10 mM. revealed a baclofen-dependent inward current that reversed
around 255 mV, which is the inversion potential of potassium in the
experimental conditions. (B) In SDC, subtraction of the current-voltage
relationships from 2150 to +10 mV measured successively in presence
of baclofen alone (baclofen) and following subsequent addition of
clonidine at 10 mM demonstrated that baclofen occluded the effect of
clonidine.
doi:10.1371/journal.pone.0016672.g003
Figure 4. a2-ARs activation in the control condition reduces
total calcium current in identified hcrt/orx neurons. (A) Total
calcium current measured in response to a voltage step from 290 to
0 mV in a typical hcrt/orx neuron before (control), during (clonidine)
and after (wash) bath-application of clonidine at 10 mM. In the insets,
the recorded neuron (arrowhead) is shown to be Hcrt/Orx-positive
(middle inset) and neurobiotin-positive (right inset). (B) Time-depen-
dent reduction of the total calcium current following transient
application of clonidine at 10 mM. Experiments were done in presence
of 10 mM NBQX, 50 mM D-APV, 30 mM bicuculline, 1 mM tetrodotoxin,
20 mM TEA, 4 mM 4-AP and 3 mM ClCs in the ACSF.
doi:10.1371/journal.pone.0016672.g004
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from the emergence of an a2-AR dependent response which
overrides the a1-AR dependent one. The reasons for the species
differences in baseline responses to noradrenaline on the one hand
and in responses to SD on the other hand, with hyperpolarizations
as shown here in rats, versus depolarisations (following potentia-
tion of glutamate responses) in mice [20] are not understood.
Functionally however, with respect to the sleepiness normally
accompanying SD (see final paragraph of Discussion), it must be
stressed that the rat model seems more relevant than the mouse
one.
This inhibitory action of clonidine in SDC is due to the opening
of GIRK channels [15,21] as indicated by the voltage-dependence
of the current elicited by the agonist with its characteristically
marked inward rectification at potentials negative to EK and its
sensitivity to minute amounts of barium. These results are
congruent with a number of studies in many different systems
indicating that inhibitory actions of a2-AR activation can be
mediated by activation of GIRK channels [14].
As clonidine was completely ineffective in CC, it appears that
the regulation of noradrenergic responses in rat hcrt/orx cells is
entirely dependent on the presence (in SDC) or absence (in CC) of
a2-AR-dependent responses. To explain the absence of response in
CC, several hypotheses can be evoked (for reviews [22–24]): a
down-regulation of GIRK channels [24], a change in the
availability of G-proteins (mediated by regulators of G-proteins,
RGS [25] or guanine-nucleotide-dissociation inhibitor proteins,
GDI [26]), a general desensitization of a2-ARs by clonidine
[14,24], and finally a down–regulation (or heterologus desensiti-
zation) of a pool of a2-ARs associated with the GIRK channels
[14,16,24].
With respect to the first hypothesis, we were able to demonstrate
that down-regulation of GIRK channels could not be involved in
the absence of response to clonidine in CC since GIRK-dependent
responses to baclofen could still be evoked in that condition. In
addition, occlusion experiments in SDC between clonidine and
baclofen showed that the population of GIRK channels respond-
ing to both agonists must be the same. The second hypothesis, that
a change in the availability of G-proteins under the regulatory
influence of RGS or GDI proteins could explain the switch
between CC and SDC, is not supported by our results either.
Indeed, in studies that have tackled the question of modulation of
responses to agonists by the availability of G-proteins, data suggest
modest shifts in dose-responses [27–29]. In our experiments
however, even at concentrations that were one thousand times
higher in CC (100 mM) than those efficient in SDC (100 nM),
clonidine was completely ineffective. The third hypothesis, that the
a2-ARs are desensitized in CC, is certainly not true for all a2-ARs,
since clonidine was still able in that condition to decrease the total
calcium current, as is the case in other preparations [17]. In
addition, for those receptors responsible for the hyperpolarization
in SDC, the mechanism is certainly not a homologous desensi-
tization involving the continuous presence of the agonist [24].
Indeed, noradrenaline release during the two conditions must be
exactly opposite to what would be needed for such an agonist-
mediated desensitization to occur. In CC, the animals have slept
for 2 hours and thus noradrenaline release must have been
relatively low, whereas during the waking associated with SD,
noradrenaline release must certainly have been higher [30,31]. It
is nonetheless during SD that the a2-dependent responses develop.
At this stage, with no evidence for either a down-regulation of
GIRK channels or a change in G-protein availability, together
with evidence for a persisting action of clonidine on calcium
currents in CC, one is left with the hypothesis that, those a2-ARs
associated with calcium channels and those associated with GIRK
channels must be differentially regulated. Those receptors
associated with GIRK channels could thus form a pool that is
down-regulated (or heterologously desensitized) in CC and which
is up-regulated (or resensitized) selectively with sleep-deprivation
to provide inhibition of hcrt/orx neurons. The signal associated
with the sleep deprivation process that triggers that change
remains to be investigated.
Functionally, the present data suggest that changing the
response of hcrt/orx neurons to noradrenaline through the
emergence of functional a2-ARs during sleep deprivation could
contribute to the increased sleepiness associated with that
condition. Regulation of adrenergic receptors could represent a
homeostatic response to the continuous discharge by the hcrt/orx
neurons that would occur during enforced waking [6]. Increasing
hyperpolarization of the hcrt/orx neurons through the a2-ARs
would serve to dampen their responsiveness and decrease their
firing such as to indirectly facilitate sleep by removing their
excitatory influence from their diverse targets, including the other
arousal systems of the brain.
Materials and Methods
Experimental conditions
Young (17–21 days) Sprague-Dawley rats (Laboratoires Charles
River, France) were maintained in a 12 h light/dark cycle (lights
on from 8:00 am to 8:00 pm) and treated according to the
regulations of the Swiss Federal Veterinary Office. The study was
reviewed and approved by the ‘‘office ve ´te ´rinaire cantonal’’
(approval ID: 31.1.1007/3248/0). As previously described,
after a normal cycle of sleep and waking, rats were either allowed
to sleep for 2 h from 8:00 to 10:00 am or kept fully awake; being
gently sleep deprived (for details see [11,32] for the same 2 hours
interval. Then, neurons were recorded between 11 am and 1 pm
in control condition (CC) and sleep deprived condition (SDC),
respectively. Some experiments were also conducted at night
(between 8 and 10 pm), in which case night-vision goggles were
used.
Slice preparation
250 mm-thick hypothalamic coronal slices containing the hcrt/
orx neurons were obtained at 10 am from CC or SD rats. Slices
were maintained in vitro for only 3 hours following sacrifice since
EEG studies and our own previous study demonstrated that the
consequences of sleep deprivation can be observed during the
three hours following the deprivation protocol [11,33]. Tissue was
left to recover for 1 hour at room temperature in artificial
cerebrospinal fluid (ACSF) containing (in mM): 130 NaCl, 5 KCl,
1.25 KH2PO4, 1.3 MgSO4, 20 NaHCO3, 10 glucose and 2.4
CaCl2, and bubbled with 95% O2 and 5% CO2. Subsequently,
individual slices were transferred to a thermoregulated (32uC)
recording chamber mounted on an upright microscope (Axioskop;
Zeiss, Oberkochen, Germany) equipped with an infrared camera
and continuously superfused at 4–5 ml/min with ACSF.
Electrophysiology
Patch pipettes (4 to 7 MV) were pulled on a DMZ universal
puller (Zeitz-Instrumente, Munich, Germany) from borosilicate
glass capillaries (GC150F-10; Harvard Apparatus, France) and
filled with a solution containing (in mM) 126 KMeSO4, 4 KCl, 5
MgCl2, 0.1 BAPTA, 10 HEPES, 8 phosphocreatine, 3 ATP, 0.1
GTP (pH 7.3, 285–300 mOsm) and 2% neurobiotin (Vector Labs,
REACTOLAB, S.A., Switzerland) to allow subsequent immuno-
histochemical identification as previously described [13]. Whole-
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current-clamp or voltage-clamp mode using Axopatch 200A or
200B amplifiers (Molecular devices, Sunnywale, CA, USA). The
membrane potential values were not compensated for junction
potential (estimated at 29.6 mV). Voltage-clamp data were
accepted when series resistance was ,20 MV and changed
,15% during recording, and analysed with Clampfit 10.0
(Molecular devices).
In voltage-clamp experiments designed to reveal a baclofen or
clonidine-dependent activation of GIRK currents, the external
potassium concentration was changed from 6.25 to 16 mM to
raise the driving force for this ion. In these experimental
conditions the equilibrium potential for potassium was estimated
from the Nernst equation as EK = RT/F*ln([K
+]out/[K
+]in)=
255 mV. 100 ms-long ramps from 2150 to +10 mV were
repeated every 10 seconds before and following addition of
clonidine or baclofen, respectively. Experiments were done in
presence of 1 mM tetrodotoxin (TTX, Latoxan, Rosans, France),
10 mM NBQX, 50 mM D-APV, 30 mM bicuculline (all from
Tocris) to block sodium action potentials and synaptic activity.
Current traces are signals averaged from three traces for ACSF,
baclofen and clonidine, respectively.
In voltage-clamp experiments designed to investigate a
clonidine-dependent effect on the total calcium current, the cells
were first identified electrophysiologically with the above intrapip-
ette solution. Then, after 20 minutes, the same electrophysiolog-
ically identified hcrt/orx cell was re-patched with a cesium-
containing intrapipette solution (in mM): CsMeSulfonate 140,
CsCl 10, Hepes 10, MgCl2 4, BAPTA 0.1, phosphocreatine 8,
Na2-ATP 2, Na2-GTP 0.4 and neurobiotin 2% (pH=7.4, 290–
310 mOsm) whereby blocking potassium currents allowed the
isolation of the total calcium current. Experiments were done in
presence of 1 mM TTX to block sodium channels; 20 mM TEA,
4 mM 4-AP, 3 mM ClCs (all from Sigma) to block potassium
channels externally and 10 mM NBQX, 50 mM D-APV, 30 mM
bicuculline (all from Tocris) to block synaptic activity. A 100 ms-
long voltage step from 290 to 0 mV was repeated every 10
seconds allowing total calcium current to be recorded before,
during and following transient application of clonidine (Sigma).
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